LPL Financial’s Viking Therapeutics VKTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.67M Sell
174,263
-5,593
-3% -$180K ﹤0.01% 2513
2025
Q4
$6.33M Sell
179,856
-16,651
-8% -$590K ﹤0.01% 2336
2025
Q3
$5.16M Buy
196,507
+58,136
+42% +$1.73M ﹤0.01% 2431
2025
Q2
$3.67M Buy
138,371
+19,758
+17% +$520K ﹤0.01% 2561
2025
Q1
$2.86M Buy
118,613
+21,911
+23% +$693K ﹤0.01% 2616
2024
Q4
$3.89M Buy
96,702
+14,873
+18% +$848K ﹤0.01% 2272
2024
Q3
$5.18M Buy
81,829
+24,326
+42% +$1.43M ﹤0.01% 1962
2024
Q2
$3.05M Buy
57,503
+4,516
+9% +$296K ﹤0.01% 2242
2024
Q1
$4.34M Buy
52,987
+3,352
+7% +$149K ﹤0.01% 1897
2023
Q4
$924K Buy
49,635
+13,820
+39% +$181K ﹤0.01% 3111
2023
Q3
$396K Sell
35,815
-2,557
-7% -$36.6K ﹤0.01% 3670
2023
Q2
$622K Buy
38,372
+5,767
+18% +$121K ﹤0.01% 3244
2023
Q1
$543K Sell
32,605
-11,045
-25% -$114K ﹤0.01% 3251
2022
Q4
$410K Buy
43,650
+4,031
+10% +$18K ﹤0.01% 3430
2022
Q3
$108K Sell
39,619
-74
-0.2% -$242 ﹤0.01% 4091
2022
Q2
$115K Buy
39,693
+13,542
+52% +$33.5K ﹤0.01% 4102
2022
Q1
$78K Sell
26,151
-1,365
-5% -$4.9K ﹤0.01% 4013
2021
Q4
$127K Sell
27,516
-4,849
-15% -$27.2K ﹤0.01% 4087
2021
Q3
$203K Buy
32,365
+5,470
+20% +$33.8K ﹤0.01% 3980
2021
Q2
$161K Buy
26,895
+1,500
+6% +$8.91K ﹤0.01% 3961
2021
Q1
$161K Buy
25,395
+11,000
+76% +$77.4K ﹤0.01% 3832
2020
Q4
$81K Hold
14,395
﹤0.01% 3704
2020
Q3
$84K Sell
14,395
-4,000
-22% -$27.5K ﹤0.01% 3395
2020
Q2
$133K Sell
18,395
-7,725
-30% -$51.3K ﹤0.01% 3243
2020
Q1
$122K Buy
26,120
+8,450
+48% +$51.9K ﹤0.01% 2950
2019
Q4
$142K Sell
17,670
-3,698
-17% -$27K ﹤0.01% 3178
2019
Q3
$147K Buy
21,368
+4,183
+24% +$31.1K ﹤0.01% 3091
2019
Q2
$143K Sell
17,185
-128,600
-88% -$1.1M ﹤0.01% 3110
2019
Q1
$1.45M Buy
+145,785
New +$1.22M ﹤0.01% 1395

Other funds holding VKTX